Flumazenil Injection, Solution
Product Images NDC 51662-1254

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 mL Vial Label (1000570 0143 9784 01 Flumazenil 5 mL)

This is a description of a medication called Flumazenil. It is an injection for intravenous use only and its National Drug Code (NDC) is 0143-784.01. The medication comes in a single-use vial containing 13 milligrams of Flumazenil, which is used to reverse the effects of certain medications on the central nervous system. The dosage should be determined by a medical professional. The medication has been manufactured and distributed by a pharmaceutical company, but the expiration date is not provided.*

FDA Label Image

Serialized Label (51662 1254 1 Flumazenil 5 Serialized)

FDA Label Image

Boxed Warning (Boxed Warning)

The use of flumazenil can lead to seizures, especially in patients who have been on benzodiazepines for long-term sedation or in overdose cases where patients are showing signs of serious cyclic antidepressant overdose. It is recommended that practitioners individualize the dosage of flumazenil and be prepared to manage seizures.*

FDA Label Image

Tabel (Clinica Pharma Tabel)

This text appears to be a table displaying different pharmacokinetic parameters of a drug. The parameters include Cmax (maximum plasma concentration), AUC (area under the curve), Vss (volume of distribution at steady state), €l (total body clearance), and half-life. The numbers in parentheses may indicate the range and percentage of population studied for each parameter.*

FDA Label Image

Chart (Clinical Pharma Chart)

This text describes a study on the effects of flumazenil on sedation reversal. Different doses of flumazenil were administered, and the magnitude and duration of sedation reversal were measured. The results were presented in a graph showing blood levels of flumazenil over time. The sedation was induced by a midazolam infusion in healthy volunteers.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.